{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:50:46Z","timestamp":1788299446906,"version":"build-2803163510"},"reference-count":27,"publisher":"Microbiology Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,7,1]]},"DOI":"10.1099\/vir.0.19088-0","type":"journal-article","created":{"date-parts":[[2003,6,16]],"date-time":"2003-06-16T23:29:24Z","timestamp":1055806164000},"page":"1781-1788","source":"Crossref","is-referenced-by-count":52,"title":["Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains"],"prefix":"10.1099","volume":"84","author":[{"given":"Javier","family":"Mart\u00edn","sequence":"first","affiliation":[{"name":"Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Crossland","sequence":"additional","affiliation":[{"name":"Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Wood","sequence":"additional","affiliation":[{"name":"Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Minor","sequence":"additional","affiliation":[{"name":"Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","first-page":"874","article-title":"Acute flaccid paralysis associated with circulating vaccine-derived poliovirus \u2013 Philippines, 2001","volume":"50","year":"2001","journal-title":"Morb Mortal Wkly Rep"},{"key":"R2","first-page":"102","article-title":"Cumulative testing experience with consecutive lots of oral poliomyelitis vaccine","author":"Cabasso","year":"1959","journal-title":"In Live Poliovirus Vaccines . First International Conference on Live Poliovirus Vaccines"},{"key":"R3","first-page":"1148","article-title":"Centers for Disease Control & Prevention","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R4","first-page":"163","article-title":"Progress with inactivated poliovirus vaccines derived from the Sabin strains","volume":"105","author":"Doi","year":"2001","journal-title":"Dev Biol"},{"key":"R5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0168-1702(99)00044-1","article-title":"Poliomyelitis eradication","volume":"62","author":"Dowdle","year":"1999","journal-title":"Virus Res"},{"key":"R6","first-page":"311","article-title":"Can post-eradication laboratory containment of wild polioviruses be achieved?","volume":"80","author":"Dowdle","year":"2002","journal-title":"Bull World Health Organ"},{"key":"R7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1099\/0022-1317-74-4-685","article-title":"Antigenic structure of poliovirus in inactivated vaccines","volume":"74","author":"Ferguson","year":"1993","journal-title":"J Gen Virol"},{"key":"R8","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/S0264-410X(00)00515-6","article-title":"Inactivated poliovirus vaccine and the final stages of poliovirus eradication","volume":"19","author":"Hovi","year":"2001","journal-title":"Vaccine"},{"key":"R9","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0264-410X(98)00409-5","article-title":"Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains","volume":"17","author":"Kersten","year":"1999","journal-title":"Vaccine"},{"key":"R10","first-page":"14","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"14","author":"Kew","year":"2002","journal-title":"Science"},{"key":"R11","first-page":"112","article-title":"Vaccination with modified active viruses","author":"Koprowski","year":"1958","journal-title":"In Poliomyelitis . Papers and Discussion Presented at the Fourth International Poliomyelitis Conference"},{"key":"R12","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1128\/JVI.68.11.7507-7515.1994","article-title":"Mouse neurovirulence determinants of poliovirus type 1 strain LS \u2013 a map to the coding regions of capsid protein VP1 and proteinase 2Apro","volume":"68","author":"Lu","year":"1994","journal-title":"J Virol"},{"key":"R13","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1128\/JVI.76.11.5339-5349.2002","article-title":"Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains","volume":"76","author":"Martin","year":"2002","journal-title":"J Virol"},{"key":"R14","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1128\/JVI.69.12.7601-7605.1995","article-title":"Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus","volume":"69","author":"McGoldrick","year":"1995","journal-title":"J Virol"},{"key":"R15","first-page":"155","article-title":"Live attenuated poliovirus vaccines","volume-title":"In","author":"Melnick","year":"1994"},{"key":"R16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/JVI.34.1.73-84.1980","article-title":"Comparative biochemical studies of type 3 poliovirus","volume":"34","author":"Minor","year":"1980","journal-title":"J Virol"},{"key":"R17","first-page":"121","article-title":"Antigenic structure of picornaviruses","volume":"161","author":"Minor","year":"1990","journal-title":"Curr Top Microbiol Immunol"},{"key":"R18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1099\/0022-1317-67-4-693","article-title":"Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee","volume":"67","author":"Minor","year":"1986","journal-title":"J Gen Virol"},{"key":"R19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0264-410X(95)00211-I","article-title":"Inactivated poliovirus vaccine: past and present experience","volume":"14","author":"Murdin","year":"1996","journal-title":"Vaccine"},{"key":"R20","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00006454-198811000-00003","article-title":"Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey","volume":"7","author":"Murph","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"R21","first-page":"205","article-title":"Noninfectious poliovirus vaccine","volume-title":"In Vaccines","author":"Salk","year":"1994"},{"key":"R22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0092-1157(89)90004-8","article-title":"Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies","volume":"17","author":"Singer","year":"1989","journal-title":"J Biol Stand"},{"key":"R23","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/clinids\/14.2.568","article-title":"Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease","volume":"14","author":"Strebel","year":"1992","journal-title":"Clin Infect Dis"},{"key":"R24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/infdis\/175.2.441","article-title":"Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge","volume":"175","author":"Taffs","year":"1997","journal-title":"J Infect Dis"},{"key":"R25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0022-2836(84)90084-6","article-title":"Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants","volume":"174","author":"Toyoda","year":"1984","journal-title":"J Mol Biol"},{"key":"R26","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/0264-410X(95)00079-G","article-title":"Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines","volume":"13","author":"Twomey","year":"1995","journal-title":"Vaccine"},{"key":"R27","volume-title":"Manual for the Virological Investigation of Poliomyelitis","year":"1997"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.19088-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T18:14:21Z","timestamp":1582222461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.19088-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,1]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7,1]]}},"URL":"https:\/\/doi.org\/10.1099\/vir.0.19088-0","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,1]]}}}